Manufacture and sale of 344 FDC drugs banned

Updated - December 04, 2021 11:34 pm IST

Published - March 15, 2016 12:00 am IST - HYDERABAD:

The government of India has prohibited manufacture, sale and distribution of 344 Fixed Dose Combination (FDC) drugs that are likely to involve risk to human beings (when safer alternatives to the said drugs were available). It has issued a gazette notification to this effect on March 10.

An expert committee said these drugs were found to have no therapeutic justification and the same was officially communicated to the Drug Control Administration (DCA) of Telangana on Monday, said Drug Controller, Dr. Akun Sabharwal.

Complete withdrawal

Following the advisory, Assistant Directors and Drug Inspectors of the DCA have been instructed to recall/ensure complete withdrawal of the said FDC drugs from the market with immediate effect and inform to the head office the quantity recalled, on a daily basis.

Also, the Telangana State Chemist and Druggist Association has been asked to inform their members to recall the drugs and refrain from sale and distribution of the same.

The Organisation of IDMA, Pharmaceutical Manufacturing Association, Bulk Drug Manufacturing Association have been requested to inform their members too, about this. A press release said the Indian Medical Association was also asked to inform it’s members not to prescribe these drugs.

A list of prohibited FDCs has been uploaded on the DCA website under the head ‘Circulars’.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.